Photobiomodulation in Dry Age Related Macular Degeneration
Recruiting
N/A
Interventional Study
Age-Related Macular Degeneration
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 180 (estimated)
- Sponsor
- Azienda Ospedaliera Universitaria Mater Domini, Catanzaro · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate effects of consecutive Yellow and Red Light Emitting Diode photobiomodulation in dry age-related macular degeneration (AMD). The main questions it aims to answer are:
* Is Yellow and Red Light Emitting Diode photobiomodulation effective in decreasing drusen volume in patients affected by dry AMD?
* Does Yellow and Red Light Emitting Diode photobiomod…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* BCVA ETDRS \> 40 L ETDRS at 4 meters
* Diagnosis of DRY AMD AREDS grade 2-3
* Ability to communicate well with the investigator and able to understand and comply with the requirements of the study
Exclusion Criteria:
* Concomitant epilepsy
* Neurological diseases
* Psychiatr…
Contacts